Allstate (NYSE:ALL) Price Target Raised to $235.00 at UBS Group

Allstate (NYSE:ALL - Get Free Report) had its price objective raised by equities research analysts at UBS Group from $230.00 to $235.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has a "buy" rating on the insurance provider's stock. UBS Group's target price would suggest a potential upside of 20.74% from the stock's current price.

Several other equities research analysts have also weighed in on ALL. Barclays increased their target price on Allstate from $172.00 to $188.00 and gave the stock an "underweight" rating in a research report on Monday. Raymond James Financial reissued a "strong-buy" rating and issued a $250.00 price target (up previously from $240.00) on shares of Allstate in a research note on Monday, May 5th. Morgan Stanley increased their price target on Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. BMO Capital Markets reissued an "outperform" rating on shares of Allstate in a research note on Friday, May 16th. Finally, Keefe, Bruyette & Woods increased their price target on Allstate from $228.00 to $235.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 7th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $227.07.

Allstate Stock Performance

NYSE ALL traded up $0.55 during trading hours on Wednesday, hitting $194.64. The company had a trading volume of 1,379,237 shares, compared to its average volume of 1,640,706. Allstate has a fifty-two week low of $158.04 and a fifty-two week high of $213.18. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.40. The business has a fifty day simple moving average of $201.11 and a 200-day simple moving average of $196.67. The firm has a market cap of $51.54 billion, a P/E ratio of 13.30, a price-to-earnings-growth ratio of 1.01 and a beta of 0.33.

Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a return on equity of 24.62% and a net margin of 6.19%. The company had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. During the same period in the prior year, the business earned $5.13 earnings per share. Allstate's quarterly revenue was up 7.8% on a year-over-year basis. Equities analysts predict that Allstate will post 18.74 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Exchange Traded Concepts LLC boosted its stake in Allstate by 7.2% during the second quarter. Exchange Traded Concepts LLC now owns 5,689 shares of the insurance provider's stock valued at $1,145,000 after buying an additional 380 shares in the last quarter. Fulton Bank N.A. boosted its stake in Allstate by 2.3% during the second quarter. Fulton Bank N.A. now owns 4,753 shares of the insurance provider's stock valued at $957,000 after buying an additional 108 shares in the last quarter. NorthCrest Asset Manangement LLC boosted its stake in Allstate by 3.0% during the second quarter. NorthCrest Asset Manangement LLC now owns 12,541 shares of the insurance provider's stock valued at $2,483,000 after buying an additional 360 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Allstate by 23.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 146,525 shares of the insurance provider's stock valued at $29,012,000 after purchasing an additional 27,575 shares during the period. Finally, Atticus Wealth Management LLC boosted its position in shares of Allstate by 216.7% in the 2nd quarter. Atticus Wealth Management LLC now owns 1,216 shares of the insurance provider's stock valued at $245,000 after purchasing an additional 832 shares during the period. Institutional investors own 76.47% of the company's stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.